$RVMD Revolution Medicines Tape Reports
Per Ticker.id: $RVMD Revolution Medicines Tape Reports — 7 podcast mentions across 3 podcasts (30 days), latest 2026-08-27 00:00 UTC.
Revolution Medicines has won FDA approval for a pill that lengthens the lives of patients with advanced pancreatic cancer. More from Bloomberg's Charlie Pellett.
Doug Krisner — Bloomberg News Now · Fed's Cook Denies Wrongdoing, Nvidia on AI Demand, More · 2026-08-27Revolution Medicines has won FDA approval for a pill that lengthens the lives of patients with advanced pancreatic cancer. More from Bloomberg's Charlie Pellett.
Doug Krisner — Bloomberg News Now · Fed’s Cook Denies Wrongdoing, Nvidia Bullish Outlook, More · 2026-08-26That is Bloomberg's Jennifer Welch. President Trump has signed an emergency order to keep some foreign-made electrical equipment out of U.S. power grids on concern over national security. This directive follows a series of cyberattacks on U.S. water facilities. Now, these cases have underscored the extent to which critical infrastructure in the U.S. can be targeted. So now the Energy Department has 120 days to publish regulations on the matter, and the Energy Secretary is permitted to impose restrictions on the use of already installed equipment to address those risks. Revolution Medicines has won FDA approval for a pill that lengthens the lives of patients with advanced pancreatic cancer. More from Bloomberg's Charlie Pellett.
Doug Krisner — Bloomberg News Now · Nvidia Says Revenue to Grow 70%, Meta Reaches Settlement, More · 2026-08-26Bloomberg's Brendan Murray reports the list includes exports from states Republicans are hoping to protect in the November midterms, like Ohio, Michigan and Pennsylvania. Revolution Medicines has won U.S. approval for a pill that lengthens the lives of patients with advanced pancreatic cancer. The once-daily drug, branded Rezonq, carries a list price of more than $475,000 a year and is one of the first medicines to broadly target RAS, a protein tied to tumor growth. Almost three-quarters of U.S. adults feel guilty when they spend on things that bring them joy instead of putting the money toward a financial goal. That's according to a report from Ally Bank. About 70% of people say they're stressed about balancing financial responsibilities with enjoying life, with 77% saying they sometimes cut back, delay, or forego things they enjoy because of financial pressure or competing priorities. That's news when you want it with Bloomberg News Now. I'm Matt Piper and this is Bloomberg.
Matt Piper — Bloomberg News Now · Meta Settlement Over Teen Addiction, Putin to Escalate War, More · 2026-08-26Yeah, I mean, in terms of drugs, there's always something exciting coming up. And if we look at cancer specifically now, because the current conversation is cancer, we have a revolutionary drug coming from Revolution Medicines for pancreatic cancer, something that is going to at least open the— fire the starting guns and actually are actually treating these patients, giving them a chance of doubling their survival. And of course, in all these numbers, there are ones who are much better treated in terms of the, you know, you go with the mean and median, but there are people in there who get much better efficacy. And it is the starting guns because we need to deal with side effect profile there. So there's that that's coming and that's going to really accelerate efforts there. There's a whole load of other stuff going on. There's other versions of these GLP-1s coming up. There are drugs for neuropsychiatric diseases that are making big waves. There are drugs for reducing your cholesterol, oral drug that recently approved. There's a lot happening, unfortunately. AI is the subject du jour, and it will keep taking and sucking the oxygen out of the room.
Sam Fazzelli — Bloomberg Intelligence · Family Offices Amass $3.8 Billion SpaceX Bet in Boost for Musk · 2026-08-17